Showing results (1-10 of 60) with videos related to
Sort By:
Pageof 6
The Journal of Investigative Dermatology|November 28, 2008
Frequencies of NRAS and BRAF mutations increase from the radial to the vertical growth phase in cutaneous melanomaVictoria R Greene, Marcella M Johnson, Elizabeth A Grimm, et al.International Journal of Pediatric Otorhinolaryngology|January 18, 2006
The bacteriostatic properties of ear tubes made of absorbable polylactic acidJames J Ludwick, Susan N Rossmann, Marcella M Johnson, et al.The Journal of Urology|January 20, 2009
Genetic deficiency of complement isoforms C4A or C4B predicts improved survival of metastatic renal cell carcinomaGhazal I Zafar, Elizabeth A Grimm, Wei Wei, et al.Annals of Internal Medicine|January 7, 2004
Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infectionsIssam Raad, Hend A Hanna, Badie Alakech, et al.Clinical Cardiology|February 16, 2006
Cardiac sequelae in Brooklyn after the September 11 terrorist attacksJianwei Feng, Daniel J Lenihan, Marcella M Johnson, et al.Oncology Reports|July 29, 2003
High prevalence of hypothyroidism among patients with cutaneous melanomaJulie A Ellerhorst, Catherine D Cooksley, Lyle Broemeling, et al.Carcinogenesis|October 4, 2005
N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cellsAnn-Marie Simeone, Stefano Colella, Ralf Krahe, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2007
Decreased expression of retinoid receptors in melanoma: entailment in tumorigenesis and prognosisNitin Chakravarti, Reuben Lotan, Abdul H Diwan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2009
Phase I study of concurrent weekly docetaxel and repeated samarium-153 lexidronam in patients with castration-resistant metastatic prostate cancerShi-Ming Tu, Paul Mathew, Franklin C Wong, et al.Cancer Research|February 20, 2004
Cyclooxygenase-2 is essential for HER2/neu to suppress N- (4-hydroxyphenyl)retinamide apoptotic effects in breast cancer cellsAnn-Marie Simeone, Yu-Jiang Li, Lyle D Broemeling, et al.Pageof 6